Reprogramming antitumor immunity.

Crompton, Joseph G; Clever, David; Vizcardo, Raul; Rao, Mahendra; Restifo, Nicholas P

Crompton, Joseph G; Clever, David; Vizcardo, Raul; Rao, Mahendra; Restifo, Nicholas P.

Afiliación

Crompton JG; National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 2QH, UK; Department of Surgery, University of California Los Angeles, Los Angeles, CA 90095, USA.
Clever D; National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 2QH, UK.
Vizcardo R; National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Rao M; Center for Regenerative Medicine, National Institutes of Health, NIH, Bethesda, MD 20892, USA.
Restifo NP; National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Center for Regenerative Medicine, National Institutes of Health, NIH, Bethesda, MD 20892, USA. Electronic address: restifo@nih.gov.

Trends Immunol ; 35(4): 178-85, 2014 Apr.

Article en En | MEDLINE | ID: mdl-24661777

Asunto(s)

Reprogramación Celular/inmunología; Inmunoterapia/métodos; Neoplasias/inmunología; Medicina Regenerativa/métodos; Medicina Regenerativa/tendencias; Animales; Humanos

Palabras clave

T cell reprogramming; cancer immunotherapy; regenerative medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Medicina Regenerativa / Reprogramación Celular / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Revista: Trends Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google